Hideki Ohnota

Isolation of human erythropoietin with monoclonal antibodies.

Shin-ichi Yanagawa, Kouseki Hirade, Hideki Ohnota et al. · Journal of Biological Chemistry · 1984 · 64 citations · Full text

Medicine, Biochemistry, Hematology +12

Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.

Hideki Ohnota, Takashi Koizumi, Naoyuki Tsutsumi et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 62 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade

Harunobu Mukaiyama, Toshihiro Nishimura, Satoko Kobayashi et al. · Bioorganic & Medicinal Chemistry · 2007 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

A novel Syk family kinase inhibitor: Design, synthesis, and structure–activity relationship of 1,2,4-triazolo[4,3-c]pyrimidine and 1,2,4-triazolo[1,5-c]pyrimidine derivatives

Akihito Hirabayashi, Harunobu Mukaiyama, Hiroaki Kobayashi et al. · Bioorganic & Medicinal Chemistry · 2008 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic β-cell line, MIN 6 cell

Hideo Mogami, Hiroshi Shibata, Romi Nobusawa et al. · European Journal of Pharmacology Molecular Pharmacology · 1994 · 35 citations

Life Sciences, Biochemistry, Pharmacology +16